| Authors: |
Diene G; French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 31059 Toulouse Cedex 9, Toulouse, France., Angulo M; Pediatric Endocrinology, NYU Langone Hospital, NY 11501, USA., Hale PM; Diabetes Clinical Development and Research, Novo Nordisk Inc., Plainsboro, NJ 08536, USA., Jepsen CH; Precision Medicine, Novo Nordisk A/S, 2860 Søborg, Denmark., Hofman PL; Liggins Institute, University of Auckland, Aukland 1023, New Zealand., Hokken-Koelega A; Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center/Sophia Children's Hospital, 3015 CN Rotterdam, The Netherlands., Ramesh C; Service Center, Novo Nordisk India, Bangalore, Karnataka 560066, India., Turan S; Department of Pediatrics, Division of Endocrinology and Diabetes, Marmara University School of Medicine, 34854 Maltepe/İstanbul, Turkey., Tauber M; French National Reference Center for Prader-Willi Syndrome, Children's Hospital, University Hospital Center of Toulouse, 31059 Toulouse Cedex 9, Toulouse, France.; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) INSERM UMR1291 - CNRS UMR5051, University of Toulouse III, 31024 Toulouse Cedex 3, Toulouse, France. |
